SMARCA4 and non-small cell lung carcinoma: In a comprehensive study of 4813 tumors from NSCLC patients, Schoenfeld et al. discovered that 212 patients (4% of the total population) exhibited class 1 SMARCA4 alterations (52% of the SMARCA4 variants) [8].